
Early MASH risk stratification, drug choice, and aligned coverage could improve outcomes, explained Zobair Younossi, MD.
Supplements and Featured Publications
about 27 years ago
Participating Facultyabout 27 years ago
Epidemiology of Pneumococcal Disease: Rationale for and Efficacy of PnC7about 27 years ago
Bibliography





